3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Neoplasms
1
Liver Diseases
1
Liver Cirrhosis
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Interventions
halofantrine
2
Sorafenib
2
trifluridine tipiracil drug combination
1
trametinib
1
toripalimab
1
tislelizumab
1
sintilimab
1
rubitecan
1
repotrectinib
1
pevonedistat
1
pembrolizumab
1
ozanimod
1
lenvatinib
1
ledipasvir, sofosbuvir drug combination
1
gadolinium ethoxybenzyl DTPA
1
fisogatinib
1
ficlatuzumab
1
camrelizumab
1
belinostat
1
avelumab
1
Trabectedin
1
Shadowing Technique, Histology
1
Ramucirumab
1
Patient Navigation
1
Oxaliplatin
1
Nutritional Status
1
Nivolumab
1
Nadroparin
1
N-monoacetylcystine
1
Magnetic Resonance Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Liver Diseases
×
Shadowing Technique, Histology
×
Clear all
NCT03405909
2021-03-02
ESCULAP
University Hospital Erlangen
Completed
517 enrolled